3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Terminated
4
Completed
4
Unknown
2
Active not recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Neoplasms
2
Thrombocythemia, Essential
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Pinealoma
1
Pancreatic Cancer Metastatic
1
Osteosarcoma
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Myeloproliferative Disorders
1
Medulloblastoma
1
Leukemia, Myelomonocytic, Chronic
1
Histiocytosis, Langerhans-Cell
1
Ependymoma
1
Carcinoma
1
Brain Neoplasms
1
Interventions
enzalutamide
33
Abiraterone Acetate
28
apalutamide
25
Radiotherapy
25
Prednisone
25
Magnetic Resonance Spectroscopy
25
Androgen Antagonists
24
Leuprolide
21
Radiosurgery
19
darolutamide
18
Docetaxel
17
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
15
Gonadotropin-Releasing Hormone
14
gallium 68 PSMA-11
12
Specimen Handling
12
Goserelin
12
pembrolizumab
11
Radiotherapy, Intensity-Modulated
11
Radiation
11
bicalutamide
10
abiraterone
10
Pluvicto
10
Carboplatin
9
Brachytherapy
9
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
9
relugolix
8
luprolide acetate gel depot
8
Standard of Care
8
Nivolumab
8
olaparib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Prostatic Neoplasms
×
Celecoxib
×
Clear all
NCT00268476
2023-04-18
STAMPEDE
Medical Research Council
Phase 2/3
Active not recruiting
11,992 enrolled